Epididymitis 

Epididymitis is defined as inflammation of the epididymis, the tightly coiled segment of the spermatic duct that connects the efferent duct from the posterior aspect of each testicle to its respective vas deferens. It is a significant cause of morbidity and is commonly observed by urologists, emergency medicine practitioners, and primary care physicians.

Epididymitis is the fifth most common urologic diagnosis in men aged 18-50 years. It is an important entity to differentiate from testicular torsion, which is a true urologic emergency. (See Epidemiology.)

Acute epididymitis is characterized by the onset of epididymal pain and swelling over a period of several days. Chronic epididymitis is characterized by epididymal pain and inflammation that lasts more than 6 weeks and may be accompanied by scrotal induration. (See Etiology.)

Although epididymitis may often be an infectious process, cultures commonly fail to demonstrate any identifiable infection. (See Workup.)

Infection that is severe and extends to the adjacent testicle is termed acute epididymo-orchitis.

It should be noted that idiopathic scrotal pain and orchalgia can be misdiagnosed as epididymitis. With a proper evaluation and careful physical examination, however, these entities can be distinguished from each other and a proper diagnosis obtained. (See History, Physical Examination, and Workup.)

Go to Emergent Management of Acute Epididymitis for complete information on this topic.

Complications

Complications associated with acute epididymitis and bacterial orchitis include the following:

• Scrotal abscess and pyocele
• Testicular infarction: Cord swelling can limit testicular artery blood flow.
• Fertility problems
• Testicular atrophy
• Cutaneous fistulization from rupture of an abscess through the tunica vaginalis (seen especially in TB)
• Recurrence, chronic epididymitis, and orchalgia

With regard to the last item above, true local pain can be distinguished from referred pain by spermatic cord injection with 1% lidocaine. Refractory pain that is not improved by analgesics has also been managed by denervation of the spermatic cord.

With regard to the above-mentioned fertility problems, sterility is uncommon after acute epididymitis, although the true incidence is unknown. Disturbances in the sperm quality secondary to leukocytospermia and inflammation are usually transient. More important is the far less common azoospermia, which is caused by the epididymal duct obstruction observed in untreated and improperly treated men with epididymitis. The incidence of this condition is unknown.

Complications associated with mumps orchitis include the following:

• Hypogonadotropic hypogonadism can occur as a result of testicular atrophy, which is observed in 30-50% of patients.
• Sterility occurs in 7-13% of affected patients; orchitis affects the testicular interstitium more than the Leydig and Sertoli cells, but sperm counts, mobility, and morphology can be affected.
• Orchalgia may develop.
• Mumps orchitis is not associated with the development of testicular tumors.

Patient education

The patient should limit activity, and the scrotum should be immobilized.

Stress that the course of antibiotics needs to be completed, and also stress the need for screening tests for and treatment of comorbid sexually transmitted diseases for the patient and his sexual partners.

For patient education information, see the Men's Health Center, the Infections Center, and the Sexual Health Center, as well as Epididymitis, Inflammation of the Testicle (Orchitis), Mumps, and Sexually Transmitted Diseases (STDs).

The epididymis is a coiled tubular structure located along the posterior aspect of the testis. It allows for the storage, maturation, and transport of sperm, connecting the efferent ducts of the testis to the vas deferens.

The image below is a diagram of the testis and epididymis.

The exact etiology of acute epididymitis is unclear; however, it is believed to be caused by the retrograde passage of urine from the prostatic urethra to the epididymis via the ejaculatory ducts and vas deferens. Obstruction of the prostate or urethra and congenital anomalies create a predisposition for reflux. Normally, the oblique angle of the ejaculatory ducts through the dense prostatic tissue prevents reflux. Fifty-six percent of men older than 60 years who have epididymitis exhibit concurrent bladder outlet obstruction (BOO), such as a urethral stricture or benign prostatic hyperplasia (BPH).

Reflux may also be induced by Valsalva or strenuous exertion. Epididymitis is commonly found to develop during strenuous exertion in conjunction with a full bladder.

Instrumentation and indwelling catheters are common risk factors for acute epididymitis.

Epididymitis may be accompanied by urethritis or prostatitis.

Acute epididymo-orchitis

The etiology of acute epididymo-orchitis varies depending the age of the patient and may involve a bacterial, nonbacterial infectious, noninfectious, or idiopathic process.

Infections with urinary coliforms (eg, E coli, Pseudomonas species, Proteus species, Klebsiella species) are the most common cause in children and in men older than 35 years. Ureaplasma urealyticum, Corynebacterium species, Mycoplasma species, and Mima polymorpha have also been isolated. Systemic Haemophilus influenzae and N meningitides infections are rare. In homosexual men, infections with coliform bacteria are also a common etiology.

Chlamydia is the most common cause in sexually active men younger than 35 years (accounting for up to 50% of cases, although laboratory evidence of chlamydia may be absent in up to 90% of cases).^{[5, 6]} Infections with Neisseria gonorrhoeae, Treponema pallidum, Trichomonas species, and Gardnerella vaginalis also occur in this population.

Tuberculous epididymitis can occur in endemic areas and is still the most common form of urogenital tuberculosis (TB). It is believed to spread hematogenously and often involves the kidneys.

Epididymo-orchitis may develop following bacille Calmette-Guérin (BCG) treatment for superficial bladder cancer (at a rate of 0.4%).

Viral epididymitis is thought to be the predominant etiology of pediatric epididymitis. It is defined by the absence of pyuria. Although mumps is the most common viral cause of epididymitis, coxsackievirus A, varicella, and echoviral infections have also been identified.

Other rare infections (eg, brucellosis, coccidioidomycosis, blastomycosis, cytomegalovirus [CMV], candidiasis, CMV in human immunodeficiency virus [HIV] infection) have been implicated in epididymitis but usually occur in immunocompromised hosts.

Roughly 1 in 1000 men who undergo vasectomy describe a postvasectomy pain syndrome of chronic, dull, aching pain in the epididymis and testicle. The pain is most likely secondary to chronic epididymal congestion of sperm and fluid that continues to be produced after the vasectomy. The epididymis can become distended from back pressure of this fluid, particularly following the close-ended vasectomy technique. When sperm extravasates from the end of the vas deferens, such as can occur in the open-ended vasectomy technique, a sperm granuloma may develop, with a resulting inflammatory reaction.

Men older than 40 years may have BOO (eg, BPH) or a urogenital malformation that predisposes them to urethrovasal reflux and the development of epididymitis.

Children may have various congenital abnormalities or functional voiding problems that increase the risk of reflux into the ejaculatory ducts. For example, epididymitis may be related to urethral abnormalities, an ectopic ureter, an ectopic vas deferens, detrusor sphincter dyssynergia, or vesicoureteral reflux.

Acute epididymo-orchitis has been described in 12-19% of individuals with Behçet syndrome. It is also associated with Henoch-Schönlein purpura in the pediatric population, most likely as part of a systemic inflammatory process. Up to 38% of patients with Henoch-Schönlein have scrotal involvement (range, 2-38%).

Amiodarone epididymitis is secondary to high drug concentrations, usually in the head of the epididymis, and can occur in up to 3-11% of patients taking the drug. This is a dose-dependent phenomenon and typically occurs at dosages greater than 200 mg daily. Epididymal levels of the drug are up to 300 times those of the serum, resulting in antiamiodarone HCl antibodies that subsequently attack the epididymis, resulting in the symptoms of epididymitis. Histologic analysis reveals focal fibrosis and lymphocytic infiltration of epididymal tissues.

Sarcoidosis affects the genitourinary system in up to 5% of cases, typically presenting with epididymal nodules. Trauma to the scrotum can also be a precipitating event, while some cases are idiopathic.

Etiology of chronic epididymitis

The etiology of chronic epididymitis includes the following:

• Inadequate treatment of acute epididymitis
• Recurrent epididymitis
• Association with a granulomatous reaction (most commonly Mycobacterium tuberculosis)
• Association with a chronic disease process such as Behçet syndrome

Etiology of acute orchitis

Causes of acute orchitis include the following:

• Viral: Mumps orchitis was once the most common etiology; however, since the introduction of the mumps vaccine in 1985, this has been virtually eliminated.
• Bacterial and pyogenic infections: Infections with E coli, Klebsiella species, Pseudomonas species, Staphylococcus species, and Streptococcus species are unusual.
• Granulomatous: T pallidum, M tuberculosis, Mycobacterium leprae, Actinomyces, and fungal diseases are rare.
• Trauma
• Idiopathic

With regard to a viral etiology, roughly one third of postpubertal boys with mumps have concomitant orchitis. Coxsackievirus type A, varicella, and echoviral, adenoviral, enteroviral, influenzal, and parainfluenzal infections are rare.

An estimated 1 in 1000 men develop epididymitis annually, and acute epididymitis accounts for more than 600,000 medical visits per year in the United States. Epididymitis is the most common cause of intrascrotal inflammation. Incidence is less than 1 case in 1,000 males per year. However, chronic epididymitis may account for up to 80% of patients presenting with scrotal pain in the outpatient setting.

The mumps, measles, and rubella (MMR) vaccine has markedly reduced the incidence of mumps orchitis.

Age-related demographics

Epididymitis is the fifth most common urologic diagnosis in men ages 18-50 years. The average age of a patient with chronic epididymitis is 49 years. Patients often experience symptoms for 5 years before diagnosis.

Acute epididymitis most commonly occurs in men aged 20-59 years (43% in men aged 20-39 y and 29% in men aged 40-59 y). Childhood (prepubertal) epididymitis is rare; testicular torsion is more common in this age group.

Structural urologic abnormalities are common in children and in men older than 40 years with acute epididymitis. Adults usually have BOO or urethral stricture. Children may have urethral abnormalities, such as a prostatic utricle, urethral duplication, posterior urethral valves, or urethrorectal fistula, or other anomalies, such as an ectopic ureter, ectopic vas deferens, detrusor sphincter dyssynergia, or vesicoureteral reflux.

Siegel et al found that 47% of prepubertal boys with epididymitis had associated urogenital abnormalities, including ectopic vas deferens or ureters, and urethral abnormalities.^[1]

Mumps orchitis occurs in 20-40% of postpubertal boys with mumps but is rare in prepubertal boys.

Pain improves within 1-3 days, but induration may take several weeks or months to resolve. Infection of the epididymis can lead to the formation of an epididymal abscess. In addition, progression of the infection can lead to involvement of the testicle, causing epididymo-orchitis or a testicular abscess. Sepsis is a potential consequence of severe infection. Bilateral epididymitis may result in sterility due to occlusion of the ductules from peritubular fibrosis.

Patients with epididymitis secondary to a sexually transmitted disease have 2-5 times the risk of acquiring and transmitting HIV. All sexual partners of patients with epididymitis secondary to a sexually transmitted disease need referral to ensure that they receive adequate testing and treatment.